Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome
- PMID: 16449315
- PMCID: PMC1798354
- DOI: 10.1136/ard.2005.045237
Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome
Abstract
Background: Annexin A5 is thought to have a role in the pathophysiology of the antiphospholipid syndrome (APS)-a syndrome characterised by recurrent thrombosis and pregnancy morbidity.
Objective: To investigate whether anti-annexin A5 immunoglobulin (Ig)M or IgG antibodies, or the -1C-->T polymorphism of annexin A5, is a risk factor for thrombosis or miscarriage, and whether the -1C-->T polymorphism is correlated with APS.
Methods: A cohort study was carried out with a population of 198 patients with primary APS, systemic lupus erythematosus or lupus-like disease. For the detection of anti-annexin A5 antibodies and the measurement of annexin A5 plasma levels, ELISA-type methods were used. The annexin A5 -1C-->T mutation was detected by restriction fragment length polymorphism.
Results: 71 patients were positive for annexin A5 IgM or IgG antibodies, of whom 53 patients were positive for anti-annexin A5 IgG antibodies and 27 of 198 patients were positive for anti-annexin A5 IgM antibodies. The prevalence of IgM or IgG anti-annexin A5 antibodies was not significantly associated with thrombosis or miscarriage on multivariate analysis. The prevalence of the -1C-->T mutation in the annexin A5 gene (46/198 patients) was significantly associated with miscarriage (odds ratio 2.7, 95% confidence interval 1.1 to 6.7, independent risk factor).
Conclusion: The detection of anti-annexin A5 antibodies does not seem relevant for estimating the risk for thrombosis or miscarriage in APS. The -1C-->T mutation was an independent risk factor for miscarriage, which is independent of APS.
Conflict of interest statement
Competing interests: All authors except BJW certify that they have no affiliation with or financial involvement in any organisation, or entity with a direct financial interest in the subject matter or materials discussed in this manuscript (eg, employment, consultancies, stock ownership, honoraria), except as disclosed in an attachment or cover letter. BJW is an employee of Stago R&D. He provided the anti‐annexin A5 kits and was of technical assistance in several experiments. Being employed by Stago R&D had no influence on BJW's collection, presentation and interpretation of the data. Any research or project support is identified in the Acknowledgements.
References
-
- Van Heerde W L, Lap P, Schoormans S, de Groot P G, Reutelingsperger C P M, Vroom T M. Localization of annexin A5 in human tissue. Annexins 2004137–43.
-
- Volker G, Moss S E. Annexins: from structure to functions. Physiol Rev 200282331–371. - PubMed
-
- Rand J H. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 20021129–37. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous